Endocrinology, Vol 129, 1513-1520, Copyright © 1991 by Endocrine Society

ARTICLES

The modulation of the expression of IL-6 and its receptor in human osteoblasts in vitro

AJ Littlewood, J Russell, GR Harvey, DE Hughes, RG Russell and M Gowen
Bath Institute for Rheumatic Diseases, University of Bath, United Kingdom.

Interleukin 6 (IL-6) probably plays a central role in the acute phase response and in haemopoiesis and may be involved in the control of bone turnover. We have studied the release of IL-6 from human trabecular bone cells treated with a variety of stimuli using a specific bioassay. In serum free medium, unstimulated human osteoblast-like cells produced IL-6 in the range of 1000-2050 pg/ml/24 h. Recombinant human interleukin 1 (IL-1 alpha) (10(-13)-10(-11) M), tumor necrosis factor alpha (TNF alpha) (10(-9)-10(-7) M) and lipopolysaccharide (5-500 ng/ml) all stimulated release of IL-6 from human bone cells. Maximal levels of 17,000 pg/ml were observed using the highest concentration of IL-1. 1,25(OH)2D3 and PTH did not stimulate IL-6 release. Using a specific sheep antihuman IL-6 antibody, all IL-6 activity could be neutralized. In parallel studies, ROS 17/2.8 rat osteosarcoma cells released around 50 pg/ml of IL-6 under basal conditions which were increased to a maximum of 900 pg/ml by treatment with PTH (10(-9) M). The cytokines were less effective and 1,25(OH)2D3 again had no effect. Modulation of expression of IL-6 mRNA in human osteoblast cells was examined using a human complementary deoxyribonucleic acid probe. The mRNA was constitutively expressed, and IL-1 (10(-11) M) and TNF (10(-7) M) induced further mRNA expression within 2 h, which was sustained over 24 h. 1,25(OH)2D3 (10(-7) M), IL-6 (2000 pg/ml), and PTH (10(-9) M) exerted no effects at any time point. Dexamethasone (10(-6) M) suppressed both basal and IL-1- and TNF-induced IL-6 mRNA expression. IL-6 receptor mRNA was constitutively expressed but was not regulated by any of the above agents. It is clear that rodent and human osteoblasts differ in their production of IL-6 and its modulation. These data support the hypothesis that IL-6 is produced locally in human bone by osteoblasts under the direction of other cytokines. This could have implications in bone remodeling, haemopoiesis, and systemic responses to local injury.

This article has been cited by other articles:

				S Takai, Y Hanai, R Matsushima-Nishiwaki, C Minamitani, T Otsuka, H Tokuda, and O Kozawa p70 S6 kinase negatively regulates fibroblast growth factor 2-stimulated interleukin-6 synthesis in osteoblasts: function at a point downstream from protein kinase C J. Endocrinol., April 1, 2008; 197(1): 131 - 137. [Abstract] [Full Text] [PDF]

				S. J. Steddon, C. W. McIntyre, N. J. Schroeder, J. M. Burrin, and J. Cunningham Impaired release of interleukin-6 from human osteoblastic cells in the uraemic milieu Nephrol. Dial. Transplant., December 1, 2004; 19(12): 3078 - 3083. [Abstract] [Full Text] [PDF]

				G. Gamberi, M. S. Benassi, P. Ragazzini, L. Pazzaglia, F. Ponticelli, C. Ferrari, A. Balladelli, M. Mercuri, M. Gigli, F. Bertoni, et al. Proteases and interleukin-6 gene analysis in 92 giant cell tumors of bone Ann. Onc., March 1, 2004; 15(3): 498 - 503. [Abstract] [Full Text] [PDF]

				E. I. Buzas, A. Hanyecz, Y. Murad, F. Hudecz, E. Rajnavolgyi, K. Mikecz, and T. T. Glant Differential Recognition of Altered Peptide Ligands Distinguishes Two Functionally Discordant (Arthritogenic and Nonarthritogenic) Autoreactive T Cell Hybridoma Clones J. Immunol., September 15, 2003; 171(6): 3025 - 3033. [Abstract] [Full Text] [PDF]

				P. Palmqvist, E. Persson, H. H. Conaway, and U. H. Lerner IL-6, Leukemia Inhibitory Factor, and Oncostatin M Stimulate Bone Resorption and Regulate the Expression of Receptor Activator of NF-{kappa}B Ligand, Osteoprotegerin, and Receptor Activator of NF-{kappa}B in Mouse Calvariae J. Immunol., September 15, 2002; 169(6): 3353 - 3362. [Abstract] [Full Text] [PDF]

				L. Bouchard, R. de Medicis, A. Lussier, P. H. Naccache, and P. E. Poubelle Inflammatory Microcrystals Alter the Functional Phenotype of Human Osteoblast-Like Cells In Vitro: Synergism with IL-1 to Overexpress Cyclooxygenase-2 J. Immunol., May 15, 2002; 168(10): 5310 - 5317. [Abstract] [Full Text] [PDF]

				C. Vermes, J. J. Jacobs, J. Zhang, G. Firneisz, K. A. Roebuck, and T. T. Glant Shedding of the Interleukin-6 (IL-6) Receptor (gp80) Determines the Ability of IL-6 to Induce gp130 Phosphorylation in Human Osteoblasts J. Biol. Chem., May 3, 2002; 277(19): 16879 - 16887. [Abstract] [Full Text] [PDF]

				J. Pfeilschifter, R. Koditz, M. Pfohl, and H. Schatz Changes in Proinflammatory Cytokine Activity after Menopause Endocr. Rev., February 1, 2002; 23(1): 90 - 119. [Abstract] [Full Text] [PDF]

				A. Lourbakos, J. Potempa, J. Travis, M. R. D'Andrea, P. Andrade-Gordon, R. Santulli, E. J. Mackie, and R. N. Pike Arginine-Specific Protease from Porphyromonas gingivalis Activates Protease-Activated Receptors on Human Oral Epithelial Cells and Induces Interleukin-6 Secretion Infect. Immun., August 1, 2001; 69(8): 5121 - 5130. [Abstract] [Full Text] [PDF]

				F. DE MIGUEL, P. MARTINEZ-FERNANDEZ, C. GUILLEN, A. VALIN, A. RODRIGO, M. E. MARTINEZ, and P. ESBRIT Parathyroid Hormone-Related Protein (107-139) Stimulates Interleukin-6 Expression in Human Osteoblastic Cells J. Am. Soc. Nephrol., April 1, 1999; 10(4): 796 - 803. [Abstract] [Full Text]

				N. Franchimont, D. Durant, S. Rydziel, and E. Canalis Platelet-derived Growth Factor Induces Interleukin-6 Transcription in Osteoblasts through the Activator Protein-1 Complex and Activating Transcription Factor-2 J. Biol. Chem., March 5, 1999; 274(10): 6783 - 6789. [Abstract] [Full Text] [PDF]

				M. E. Nuttall, J. N. Bradbeer, G. B. Stroup, D. P. Nadeau, S. J. Hoffman, H. Zhao, S. Rehm, and M. Gowen Idoxifene: A Novel Selective Estrogen Receptor Modulator Prevents Bone Loss and Lowers Cholesterol Levels in Ovariectomized Rats and Decreases Uterine Weight in Intact Rats Endocrinology, December 1, 1998; 139(12): 5224 - 5234. [Abstract] [Full Text] [PDF]

				R. S. Taichman, M. J. Reilly, R. S. Verma, and S. G. Emerson Augmented Production of Interleukin-6 by Normal Human Osteoblasts in Response to CD34+ Hematopoietic Bone Marrow Cells In Vitro Blood, February 15, 1997; 89(4): 1165 - 1172. [Abstract] [Full Text] [PDF]

				E. M. Greenfield, M. C. Horowitz, and S. A. Lavish Stimulation by Parathyroid Hormone of Interleukin-6 and Leukemia Inhibitory Factor Expression in Osteoblasts Is an Immediate-early Gene Response Induced by cAMP Signal Transduction J. Biol. Chem., May 3, 1996; 271(18): 10984 - 10989. [Abstract] [Full Text] [PDF]

				S. S. Manji, H. Zhou, D. M. Findlay, T. J. Martin, and K. W. Ng Tumor Necrosis Factor [IMAGE] Facilitates Nuclear Actions of Retinoic Acid to Regulate Expression of the Alkaline Phosphatase Gene in Preosteoblasts J. Biol. Chem., April 14, 1995; 270(15): 8958 - 8962. [Abstract] [Full Text] [PDF]